Traffic

Traffic encourages and facilitates the publication of papers in any field relating to intracellular transport in health and disease. Traffic papers span disciplines such as developmental biology, neuroscience, innate and adaptive immunity, epithelial cell biology, intracellular pathogens and host-pathogen interactions, among others using any eukaryotic model system. Areas of particular interest include protein, nucleic acid and lipid traffic, molecular motors, intracellular pathogens, intracellular proteolysis, nuclear import and export, cytokinesis and the cell cycle, the interface between signaling and trafficking or localization, protein translocation, the cell biology of adaptive an innate immunity, organelle biogenesis, metabolism, cell polarity and organization, and organelle movement.

All aspects of the structural, molecular biology, biochemistry, genetics, morphology, intracellular signaling and relationship to hereditary or infectious diseases will be covered. Manuscripts must provide a clear conceptual or mechanistic advance. The editors will reject papers that require major changes, including addition of significant experimental data or other significant revision.

Traffic will consider manuscripts of any length, but encourages authors to limit their papers to 16 typeset pages or less.

Traffic 鼓励和促进发表与健康和疾病中的细胞内运输有关的任何领域的论文。Traffic 论文涵盖了发育生物学、神经科学、先天和适应性免疫、上皮细胞生物学、细胞内病原体和宿主-病原体相互作用等学科，其中使用任何真核模型系统。特别感兴趣的领域包括蛋白质、核酸和脂质运输、分子马达、细胞内病原体、细胞内蛋白水解、核进出口、胞质分裂和细胞周期、信号传导与运输或定位之间的界面、蛋白质易位、适应性和先天免疫的细胞生物学、细胞器的生物发生、代谢、细胞极性和组织以及细胞器运动。

将涵盖结构、分子生物学、生物化学、遗传学、形态学、细胞内信号传导以及与遗传或传染病的关系的所有方面。手稿必须提供清晰的概念或机制进展。编辑将拒绝需要进行重大修改的论文，包括添加重要实验数据或其他重大修订。

Traffic 会考虑任何长度的稿件，但鼓励作者将论文限制在 16 页排版页或更少。

该刊已被国际权威数据库SCIE收录，该刊致力于发表经过严格同行评审的高质量原创文章，反映生物-细胞生物学领域的新进展、新技术、新成果，促进该领域科研交流和科研成果转化。该刊2023年影响因子为3.6，平均审稿速度为 约2月 ，近四年来没有被列入预警名单。如果您需要投稿发表服务及指导，可以联系我们的客服老师，我们专业专注服务期刊投稿协助10年，为您提供期刊投稿个性化定制服务，并且我们确保严格保密您的个人信息及稿件内容。